Annual D&A
$1.71 M
-$112.00 K-6.16%
31 December 2023
Summary:
UroGen Pharma annual depreciation & amortization is currently $1.71 million, with the most recent change of -$112.00 thousand (-6.16%) on 31 December 2023. During the last 3 years, it has fallen by -$339.00 thousand (-16.59%). URGN annual D&A is now -16.59% below its all-time high of $2.04 million, reached on 31 December 2020.URGN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$266.00 K
+$3000.00+1.14%
30 September 2024
Summary:
UroGen Pharma quarterly depreciation & amortization is currently $266.00 thousand, with the most recent change of +$3000.00 (+1.14%) on 30 September 2024. Over the past year, it has dropped by -$149.00 thousand (-35.90%). URGN quarterly D&A is now -56.75% below its all-time high of $615.00 thousand, reached on 31 December 2020.URGN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.30 M
-$149.00 K-10.25%
30 September 2024
Summary:
UroGen Pharma TTM depreciation & amortization is currently $1.30 million, with the most recent change of -$149.00 thousand (-10.25%) on 30 September 2024. Over the past year, it has dropped by -$427.00 thousand (-24.67%). URGN TTM D&A is now -36.20% below its all-time high of $2.04 million, reached on 31 December 2020.URGN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.2% | -35.9% | -24.7% |
| 3 y3 years | -16.6% | -41.1% | -32.7% |
| 5 y5 years | +308.9% | -14.2% | +31.4% |
URGN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -16.6% | at low | -44.1% | +1.1% | -32.7% | at low |
| 5 y | 5 years | -16.6% | +308.9% | -56.8% | +1.1% | -36.2% | +31.4% |
| alltime | all time | -16.6% | +1408.8% | -56.8% | +1464.7% | -36.2% | +2797.8% |
UroGen Pharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $266.00 K(+1.1%) | $1.30 M(-10.3%) |
| June 2024 | - | $263.00 K(-25.1%) | $1.45 M(-10.4%) |
| Mar 2024 | - | $351.00 K(-17.2%) | $1.62 M(-4.9%) |
| Dec 2023 | $1.71 M(-6.2%) | $424.00 K(+2.2%) | $1.71 M(-1.5%) |
| Sept 2023 | - | $415.00 K(-3.7%) | $1.73 M(-1.1%) |
| June 2023 | - | $431.00 K(-0.9%) | $1.75 M(-2.5%) |
| Mar 2023 | - | $435.00 K(-3.3%) | $1.80 M(-1.2%) |
| Dec 2022 | $1.82 M(+2.5%) | $450.00 K(+3.4%) | $1.82 M(-0.1%) |
| Sept 2022 | - | $435.00 K(-8.6%) | $1.82 M(-0.9%) |
| June 2022 | - | $476.00 K(+4.4%) | $1.83 M(+1.9%) |
| Mar 2022 | - | $456.00 K(+1.1%) | $1.80 M(+1.6%) |
| Dec 2021 | $1.77 M(-13.3%) | $451.00 K(-0.2%) | $1.77 M(-8.5%) |
| Sept 2021 | - | $452.00 K(+2.3%) | $1.94 M(-2.3%) |
| June 2021 | - | $442.00 K(+3.3%) | $1.98 M(-1.6%) |
| Mar 2021 | - | $428.00 K(-30.4%) | $2.02 M(-1.4%) |
| Dec 2020 | $2.04 M | $615.00 K(+23.5%) | $2.04 M(+11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $498.00 K(+4.8%) | $1.83 M(+11.5%) |
| June 2020 | - | $475.00 K(+4.2%) | $1.64 M(+11.5%) |
| Mar 2020 | - | $456.00 K(+14.0%) | $1.47 M(+11.2%) |
| Dec 2019 | $1.32 M(+217.5%) | $400.00 K(+29.0%) | $1.32 M(+33.5%) |
| Sept 2019 | - | $310.00 K(+1.3%) | $992.00 K(+34.1%) |
| June 2019 | - | $306.00 K(-0.6%) | $740.00 K(+52.6%) |
| Mar 2019 | - | $308.00 K(+352.9%) | $485.00 K(+16.3%) |
| Dec 2018 | $417.00 K(+101.4%) | $68.00 K(+17.2%) | $417.00 K(+2.5%) |
| Sept 2018 | - | $58.00 K(+13.7%) | $407.00 K(+11.2%) |
| June 2018 | - | $51.00 K(-78.8%) | $366.00 K(-9.0%) |
| Mar 2018 | - | $240.00 K(+313.8%) | $402.00 K(+94.2%) |
| Dec 2017 | $207.00 K(-2.8%) | $58.00 K(+241.2%) | $207.00 K(+38.9%) |
| Sept 2017 | - | $17.00 K(-80.5%) | $149.00 K(+12.9%) |
| June 2017 | - | $87.00 K(+93.3%) | $132.00 K(+193.3%) |
| Mar 2017 | - | $45.00 K | $45.00 K |
| Dec 2016 | $213.00 K(+88.5%) | - | - |
| Dec 2015 | $113.00 K | - | - |
FAQ
- What is UroGen Pharma annual depreciation & amortization?
- What is the all time high annual D&A for UroGen Pharma?
- What is UroGen Pharma annual D&A year-on-year change?
- What is UroGen Pharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for UroGen Pharma?
- What is UroGen Pharma quarterly D&A year-on-year change?
- What is UroGen Pharma TTM depreciation & amortization?
- What is the all time high TTM D&A for UroGen Pharma?
- What is UroGen Pharma TTM D&A year-on-year change?
What is UroGen Pharma annual depreciation & amortization?
The current annual D&A of URGN is $1.71 M
What is the all time high annual D&A for UroGen Pharma?
UroGen Pharma all-time high annual depreciation & amortization is $2.04 M
What is UroGen Pharma annual D&A year-on-year change?
Over the past year, URGN annual depreciation & amortization has changed by -$112.00 K (-6.16%)
What is UroGen Pharma quarterly depreciation & amortization?
The current quarterly D&A of URGN is $266.00 K
What is the all time high quarterly D&A for UroGen Pharma?
UroGen Pharma all-time high quarterly depreciation & amortization is $615.00 K
What is UroGen Pharma quarterly D&A year-on-year change?
Over the past year, URGN quarterly depreciation & amortization has changed by -$149.00 K (-35.90%)
What is UroGen Pharma TTM depreciation & amortization?
The current TTM D&A of URGN is $1.30 M
What is the all time high TTM D&A for UroGen Pharma?
UroGen Pharma all-time high TTM depreciation & amortization is $2.04 M
What is UroGen Pharma TTM D&A year-on-year change?
Over the past year, URGN TTM depreciation & amortization has changed by -$427.00 K (-24.67%)